Pointing the trident in the right direction: recognizing spinal neurosarcoidosis through a specific MRI pattern

We herein report the case of a 51-year-old male presenting with progressive neurological symptoms, including numbness, tingling below the umbilicus, urinary difficulty, constipation, and weakness. Following a recent coronavirus disease 2019 (COVID-19) vaccination, magnetic resonance imaging (MRI) ([Figure 1]) revealed longitudinally extensive transverse myelitis (LETM) with a trident-shaped pattern on axial sequences, a hallmark of spinal neurosarcoidosis.[1] [2] [3] Positron emission tomography-computed tomography ([Figure 2]) demonstrated multiple hypermetabolic hilar and mediastinal lymphadenopathies, further supporting this diagnosis, particularly given the possibility of false-positive aquaporin-4-immunoglobulin G (AQP4-IgG) enzyme-linked immunosorbent assay (ELISA) results.[4] Early recognition of the trident sign enabled the prompt initiation of corticosteroids and immunosuppressive therapy, highlighting the diagnostic utility of this specific MRI pattern in an appropriate clinical scenario, with primary spinal cord lymphoma as a differential diagnosis.[5]

Figure 1 Magnetic resonance imaging of the thoracic spine in sagittal (A–D) and axial views (E–F). Evidence of longitudinally extensive transverse myelitis at the cervicothoracic junction is observed, associated with significant edema and spinal cord swelling (blue braces). Notably, a contrast-enhancing component (white asterisks) in the posterior column and central regions, extending toward the pial/subpial surface and central ependymal canal, demonstrates T2-weighted/ short tau inversion recovery (STIR) hyposignal and exhibits a “trident-shaped head” appearance on axial images. The dorsal enhancement likely results from granulomatous inflammation spreading via perivascular pathways and may be influenced by meningeal lymphatic drainage and increased vascular permeability, predisposing this region to inflammation.

Figure 2 Positron emission tomography-computed tomography scan with fluorodeoxyglucose (FDG) in sagittal (A), coronal (B–C), and axial (D–E) views. No significant FDG uptake was observed in the cervicothoracic spinal cord lesion. However, multiple mediastinal, hilar, and precarinal lymphadenopathies demonstrated high radiotracer uptake, suggesting a granulomatous inflammatory process.

Authors' Contributions

Conceptualization: AK; Methodology: MLD; Project administration: MLD, LFF; Supervision: LFF, KJA; Validation: LFF, KAJ; Writing – review & editing: LFF.

Data Availability Statement

The data used to support the findings of the present study are included within the article.

Editor-in-Chief: Ayrton Roberto Massaro.

Associate Editor: Luis Filipe de Souza Godoy.

Publikationsverlauf

Eingereicht: 24. Dezember 2024

Angenommen: 13. Februar 2025

Artikel online veröffentlicht:
13. Mai 2025

• References

• 1 Gibbons E, Whittam D, Jacob A, Huda S. Images of the month 1: Trident sign and neurosarcoidosis. Clin Med (Lond) 2021; 21 (06) e667-e668
• 2 Zalewski NL, Krecke KN, Weinshenker BG, Aksamit AJ, Conway BL, McKeon A, Flanagan EP. Central canal enhancement and the trident sign in spinal cord sarcoidosis. Neurology 2016; 87 (07) 743-744
• 3 Beitollahi A, Berry H, Gulotta P, Morales R, Milburn J. Trident Sign: The Key Magnetic Resonance Imaging Finding Distinguishing Spinal Cord Sarcoidosis From Multiple Sclerosis and Seropositive Neuromyelitis Optica Spectrum Disorder. Ochsner J 2024; 24 (04) 298-302
• 4 Jolliffe EA, Keegan BM, Flanagan EP. Trident sign trumps Aquaporin-4-IgG ELISA in diagnostic value in a case of longitudinally extensive transverse myelitis. Mult Scler Relat Disord 2018; 23: 7-8
• 5 Griffin KJ, Toledano M, Flanagan EP, Mustafa R. “Trident Sign” in Primary CNS B-Cell Spinal Cord Lymphoma. Neurology 2023; 101 (19) 857-858